Quidel Cp (QDEL) |
|
212.58 11.34 (5.64%)
|
01-21 01:02 |
|
Open: |
202 |
Pre. Close: |
201.24 |
|
High:
|
213.855 |
Low:
|
201.42 |
|
Volume:
|
935,425 |
Market Cap:
|
8,943M |
|
|
|
|
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
214.006 - 215.021 |
215.021 - 215.974 |
|
Low:
|
198.902 - 200.035 |
200.035 - 201.098 |
|
Close:
|
210.66 - 212.498 |
212.498 - 214.223 |
|
Technical analysis |
as of: 2021-01-20 4:51:26 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 249.78 One year: 291.75 |
| Support: |
Support1: 189.84 Support2: 175.00 |
| Resistance: |
Resistance1: 213.85 Resistance2: 249.78 |
| Pivot: |
196.73 |
| Moving Average: |
MA(5): 202.86 MA(20): 197.04
MA(100): 208.63  MA(250): 178.62 |
| MACD: |
MACD(12,26): 1.49 Signal(9): -0.60 |
| Stochastic oscillator: |
%K(14,3): 82.45 %D(3): 73.79 |
| RSI: |
RSI(14): 58.67 |
| 52-week: |
High: 306.72 Low: 72.99 Change(%): 177.0 |
| Average Vol(K): |
3-Month: 94897 10-Days: 126353 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.QDEL has closed below upper band by 5.2%. Bollinger Bands are 51.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to QDEL's normal range. The bands have been in this narrow range for 34 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Tue, 03 Nov 2020
Where Does Quidel Corporation (QDEL) Stock Fall in the Diagnostics & Research Field? - InvestorsObserver
Mon, 05 Oct 2020
IBD Live Q&A And Two Key Stock Lists For Oct. 5, 2020 - Investor's Business Daily
Thu, 09 Apr 2020
IBD Live Q&A Summary, Stock Lists For Thursday, April 9, 2020 - Investor's Business Daily
Fri, 20 Mar 2020
IBD Live Q&A As Well As Key Stock List For March 20, 2020 - Investor's Business Daily
Sun, 22 Sep 2019
Liberty Global plc - Consenus Indicates Potential -100.0% Downside - DirectorsTalk Interviews
Wed, 28 Aug 2019
Form N-PX MUTUAL FUND SERIES TRUST For: Jun 30 - StreetInsider.com
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Outperform |
Price to Earnings: |
Outperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
42 |
| Shares Float (M) |
38 |
|
% Held by Insiders
|
11.79 |
|
% Held by Institutions
|
87.22 |
|
Shares Short (K)
|
2,200 |
|
Shares Short P. Month (K)
|
2,510 |
Stock Financials |
|
EPS
|
8.540 |
|
EPS Est This Year
|
0.290 |
|
EPS Est Next Year
|
1.260 |
|
Book Value (p.s.)
|
20.200 |
|
Profit Margin
|
36.91 |
|
Operating Margin
|
48.41 |
|
Return on Assets (ttm)
|
28.7 |
|
Return on Equity (ttm)
|
53.6 |
|
Qtrly Rev. Growth
|
276.4 |
|
Gross Profit (p.s.)
|
7.626 |
|
Sales Per Share
|
23.770 |
|
EBITDA (p.s.)
|
12.774 |
|
Qtrly Earnings Growth
|
1335.40 |
|
Operating Cash Flow (M)
|
238 |
|
Levered Free Cash Flow (M)
|
90 |
Stock Valuations |
|
PE Ratio
|
24.89 |
|
PEG Ratio
|
|
|
Price to Book value
|
10.52 |
|
Price to Sales
|
8.94 |
|
Price to Cash Flow
|
37.52 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
